Financial Ratios CorVel Corporation

Stocks

CRVL

US2210061097

Healthcare Facilities & Services

Market Closed - Nasdaq 16:00:00 2026-09-09 EDT			5-day change	1st Jan Change
66.44 ^USD	-1.82%		-4.73%	-1.82%

08-05	CorVel Corporation, Q1 2027 Earnings Call, Aug 05, 2026
08-05	Tranche Update on CorVel Corporation's Equity Buyback Plan announced on November 12, 1996.	CI

555.ovLqzzHqjsdoakdHpoAsgcCCy1NthDDaS1oAuTdINRU.7KaCqwmHy70sJCoix_Vmt4XTsWMy9nijexkwzHkFWHnFra_9cLvssFsAcw

Published financial data: CORVEL CORPORATION

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: March	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)	2026 (USD)
Revenues	646M	719M	795M	896M	959M
Total Revenues	646M	719M	795M	896M	959M
Cost of Goods Sold, Total	494M	560M	624M	686M	726M
Gross Profit	152M	158M	172M	210M	233M
Selling General & Admin Expenses, Total	67.6M	73.7M	76.59M	88.9M	89.73M
Other Operating Expenses, Total	67.6M	73.7M	76.59M	88.9M	89.73M
Operating Income	84.51M	84.55M	95.1M	121M	143M
EBT, Excl. Unusual Items	84.51M	84.55M	95.1M	121M	143M
EBT, Incl. Unusual Items	84.51M	84.55M	95.1M	121M	143M
Income Tax Expense	18.1M	18.19M	18.85M	25.66M	32.79M
Earnings From Continuing Operations	66.41M	66.36M	76.25M	95.16M	110M
Net Income to Company	66.41M	66.36M	76.25M	95.16M	110M
Net Income - (IS)	66.41M	66.36M	76.25M	95.16M	110M
Net Income to Common Incl Extra Items	66.41M	66.36M	76.25M	95.16M	110M
Net Income to Common Excl. Extra Items	66.41M	66.36M	76.25M	95.16M	110M
Per Share Items
Net EPS - Basic	1.25	1.28	1.48	1.85	2.15
Basic EPS - Continuing Operations	1.25	1.28	1.48	1.85	2.15
Basic Weighted Average Shares Outstanding	53.26M	51.98M	51.37M	51.38M	51.28M
Net EPS - Diluted	1.22	1.26	1.47	1.83	2.14
Diluted EPS - Continuing Operations	1.22	1.26	1.47	1.83	2.14
Diluted Weighted Average Shares Outstanding	54.38M	52.78M	52.04M	51.99M	51.62M
Normalized Basic EPS	0.99	1.02	1.16	1.47	1.74
Normalized Diluted EPS	0.97	1	1.14	1.45	1.73
Supplemental Items
EBITDA	108M	110M	121M	150M	175M
EBITA	84.95M	84.98M	95.52M	121M	143M
EBIT	84.51M	84.55M	95.1M	121M	143M
EBITDAR	123M	123M	132M	160M	184M
Effective Tax Rate - (Ratio)	21.42	21.51	19.82	21.24	22.91
Current Domestic Taxes	15.8M	20.1M	22.17M	30.82M	28.01M
Total Current Taxes	15.8M	20.1M	22.17M	30.82M	28.01M
Deferred Domestic Taxes	2.3M	-1.91M	-3.32M	-5.16M	4.78M
Total Deferred Taxes	2.3M	-1.91M	-3.32M	-5.16M	4.78M
Normalized Net Income	52.82M	52.85M	59.44M	75.52M	89.46M
Supplemental Operating Expense Items
General and Administrative Expenses	67.6M	73.7M	76.59M	88.9M	89.73M
Net Rental Expense, Total	14.28M	12.83M	10.66M	9.85M	8.81M
Stock-Based Comp., COGS (Total)	2.06M	2.57M	2.8M	2.79M	2.64M
Stock-Based Comp., G&A Exp. (Total)	3.14M	2.99M	2.18M	2.92M	2.77M
Total Stock-Based Compensation	5.2M	5.56M	4.98M	5.71M	5.41M

Fiscal Period: March	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)	2026 (USD)
Assets
Cash And Equivalents	97.5M	71.33M	106M	171M	233M
Total Cash And Short Term Investments	97.5M	71.33M	106M	171M	233M
Accounts Receivable, Total	82.59M	81.03M	97.11M	104M	101M
Total Receivables	82.59M	81.03M	97.11M	104M	101M
Prepaid Expenses	12.76M	9.57M	9.25M	10.51M	10.92M
Other Current Assets, Total	72.15M	81.84M	90.31M	101M	117M
Total Current Assets	265M	244M	302M	387M	462M
Gross Property Plant And Equipment	158M	150M	140M	142M	353M
Accumulated Depreciation	-76.02M	-73.62M	-67M	-71.45M	-263M
Net Property Plant And Equipment	81.48M	76.8M	72.78M	70.12M	89.49M
Long-term Investments	-	-	-	-	-
Goodwill	36.81M	36.81M	36.81M	36.81M	36.81M
Other Intangibles, Total	31.48M	34.94M	37.99M	43.19M	49.84M
Deferred Tax Assets Long-Term	-	224K	3.54M	8.7M	3.92M
Other Long-Term Assets, Total	481K	1.38M	1.32M	454K	618K
Total Assets	415M	394M	455M	546M	643M
Liabilities
Accounts Payable, Total	14.08M	15.06M	16.41M	15.42M	24.32M
Accrued Expenses, Total	48.01M	35.68M	40.9M	46.84M	48.16M
Current Portion of Leases	13.35M	9.9M	8.86M	8.13M	7.42M
Current Income Taxes Payable	-	251K	221K	1.37M	227K
Unearned Revenue Current, Total	25.8M	26.98M	29.96M	30.81M	32.24M
Other Current Liabilities	70.13M	80.02M	88.14M	101M	116M
Total Current Liabilities	171M	168M	184M	204M	228M
Long-Term Leases	29.79M	23.86M	22.53M	19.95M	20.69M
Deferred Tax Liability Non Current	1.69M	-	-	-	-
Total Liabilities	203M	192M	207M	224M	249M
Common Stock, Total	3K	3K	3K	5K	5K
Additional Paid In Capital	202M	219M	234M	250M	269M
Retained Earnings	665M	732M	808M	903M	1.01B
Treasury Stock	-655M	-748M	-794M	-832M	-888M
Total Common Equity	212M	202M	248M	322M	394M
Total Equity	212M	202M	248M	322M	394M
Total Liabilities And Equity	415M	394M	455M	546M	643M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	52.47M	51.43M	51.37M	51.35M	50.69M
ECS Total Common Shares Outstanding	52.71M	51.51M	51.39M	51.36M	50.91M
Book Value / Share	4.03	3.93	4.82	6.27	7.74
Tangible Book Value	144M	130M	173M	242M	308M
Tangible Book Value Per Share	2.73	2.53	3.36	4.71	6.04
Total Debt	43.14M	33.76M	31.4M	28.08M	28.11M
Net Debt	-54.36M	-37.57M	-74.17M	-143M	-205M
Debt Equivalent Oper. Leases	114M	103M	85.3M	78.79M	70.5M
Account Code - Inventory Valuation	3	3	3	3	3
Land - (BS)	11.08M	11.08M	11.12M	11.05M	11.05M
Machinery, Total	77.38M	68.25M	66.61M	65.43M	76.79M
Full Time Employees	4.23K	4.44K	4.87K	5.08K	5.24K
Accumulated Allowance for Doubtful Accounts (Supple)	2.56M	2.82M	4.24M	7.69M	3.97M

Fiscal Period: March	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)	2026 (USD)
Net Income	66.41M	66.36M	76.25M	95.16M	110M
Depreciation & Amortization - CF	23.48M	24.7M	25.83M	29.15M	31.59M
Amortization of Goodwill and Intangible Assets - (CF)	435K	425K	423K	383K	175K
Depreciation & Amortization, Total	23.92M	25.12M	26.25M	29.54M	31.76M
Asset Writedown & Restructuring Costs	122K	415K	290K	443K	710K
Stock-Based Compensation (CF)	5.2M	5.56M	4.98M	5.71M	5.41M
Provision and Write-off of Bad Debts	158K	1.22M	1.83M	3.44M	115K
Other Operating Activities, Total	2.3M	-1.91M	-3.32M	-5.16M	4.78M
Change In Accounts Receivable	-18.02M	336K	-17.9M	-10.46M	2.7M
Change In Accounts Payable	1.42M	-4.4M	1.32M	162K	-728K
Change in Other Net Operating Assets	-14.28M	-10.42M	9.53M	8.47M	546K
Cash from Operations	67.22M	82.29M	99.24M	127M	156M
Capital Expenditure	-29.82M	-26.32M	-29.24M	-35.76M	-45.36M
Investment in Marketable and Equity Securities, Total	-	-	-	-	-
Cash from Investing	-29.82M	-26.32M	-29.24M	-35.76M	-45.36M
Issuance of Common Stock	10.47M	11.53M	9.95M	11.07M	8.41M
Repurchase of Common Stock	-90.08M	-93.68M	-45.71M	-37.6M	-56.21M
Cash from Financing	-79.62M	-82.14M	-35.76M	-26.54M	-47.8M
Net Change in Cash	-42.21M	-26.18M	34.23M	65.02M	62.49M
Supplemental Items
Cash Income Tax Paid (Refund)	19.4M	19.99M	22.87M	28.1M	31.14M
Levered Free Cash Flow	22.18M	52.22M	54.85M	75.85M	92.89M
Unlevered Free Cash Flow	22.18M	52.22M	54.85M	75.85M	92.89M
Change In Net Working Capital	29.94M	4.99M	6.58M	-838K	-11.62M

Fiscal Period: March	2022 (USD)	2023 (USD)	2024 (USD)	2025 (USD)	2026 (USD)
Profitability
Return on Assets	12.58	13.06	14.01	15.09	15.05
Return on Total Capital	19.91	21.51	23.08	24.01	23.16
Return On Equity %	30.69	32.02	33.9	33.41	30.81
Return on Common Equity	30.69	32.02	33.9	33.41	30.81
Margin Analysis
Gross Profit Margin %	23.54	22.02	21.59	23.42	24.29
SG&A Margin	10.46	10.26	9.63	9.93	9.36
EBITDA Margin %	16.78	15.26	15.26	16.79	18.25
EBITA Margin %	13.14	11.83	12.01	13.53	14.95
EBIT Margin %	13.08	11.77	11.96	13.49	14.93
Income From Continuing Operations Margin %	10.28	9.24	9.59	10.63	11.51
Net Income Margin %	10.28	9.24	9.59	10.63	11.51
Net Avail. For Common Margin %	10.28	9.24	9.59	10.63	11.51
Normalized Net Income Margin	8.17	7.35	7.47	8.43	9.33
Levered Free Cash Flow Margin	3.43	7.27	6.9	8.47	9.69
Unlevered Free Cash Flow Margin	3.43	7.27	6.9	8.47	9.69
Asset Turnover
Asset Turnover	1.54	1.78	1.87	1.79	1.61
Fixed Assets Turnover	7.62	9.08	10.63	12.53	12.01
Receivables Turnover (Average Receivables)	8.77	8.78	8.93	8.9	9.33
Short Term Liquidity
Current Ratio	1.55	1.45	1.64	1.9	2.03
Quick Ratio	1.05	0.91	1.1	1.35	1.47
Operating Cash Flow to Current Liabilities	0.39	0.49	0.54	0.62	0.68
Days Sales Outstanding (Average Receivables)	41.6	41.56	40.99	41.01	39.11
Average Days Payable Outstanding	9.76	9.49	9.23	8.47	10
Long Term Solvency
Total Debt/Equity	20.31	16.7	12.68	8.72	7.13
Total Debt / Total Capital	16.88	14.31	11.25	8.02	6.66
LT Debt/Equity	14.03	11.8	9.1	6.2	5.25
Long-Term Debt / Total Capital	11.66	10.11	8.08	5.7	4.9
Total Liabilities / Total Assets	48.85	48.68	45.53	41.03	38.69
Total Debt / EBITDA	0.35	0.28	0.24	0.18	0.15
Net Debt / EBITDA	-0.44	-0.31	-0.56	-0.89	-1.12
Total Debt / (EBITDA - Capex)	0.46	0.35	0.31	0.23	0.2
Net Debt / (EBITDA - Capex)	-0.59	-0.39	-0.72	-1.15	-1.48
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	16.93	11.19	10.68	12.61	7.03
Gross Profit, 1 Yr. Growth %	23.05	4.04	8.49	22.15	11.03
EBITDA, 1 Yr. Growth %	31.25	1.15	10.65	23.9	16.32
EBITA, 1 Yr. Growth %	42.5	0.04	12.41	26.89	18.23
EBIT, 1 Yr. Growth %	42.82	0.05	12.47	27.05	18.46
Earnings From Cont. Operations, 1 Yr. Growth %	43.26	-0.07	14.9	24.8	15.95
Net Income, 1 Yr. Growth %	43.26	-0.07	14.9	24.8	15.95
Normalized Net Income, 1 Yr. Growth %	42.82	0.05	12.47	27.05	18.46
Diluted EPS Before Extra, 1 Yr. Growth %	43.53	3.01	16.71	24.49	16.94
Accounts Receivable, 1 Yr. Growth %	27.6	-1.88	19.84	7.23	-2.7
Net Property, Plant and Equip., 1 Yr. Growth %	-7.45	-5.75	-5.22	-3.66	27.62
Total Assets, 1 Yr. Growth %	-2.24	-5.14	15.42	20.08	17.77
Tangible Book Value, 1 Yr. Growth %	-6.17	-9.5	32.53	40	27.11
Common Equity, 1 Yr. Growth %	-3.63	-4.81	22.49	30.02	22.44
Cash From Operations, 1 Yr. Growth %	-28.77	22.41	20.6	28.29	22.25
Capital Expenditures, 1 Yr. Growth %	72.93	-11.73	11.09	22.28	26.85
Levered Free Cash Flow, 1 Yr. Growth %	-70	135.47	5.04	38.27	22.47
Unlevered Free Cash Flow, 1 Yr. Growth %	-70	135.47	5.04	38.27	22.47
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	4.46	14.03	10.94	11.64	9.78
Gross Profit, 2 Yr. CAGR %	9.91	13.14	6.24	15.12	16.46
EBITDA, 2 Yr. CAGR %	14.14	15.22	5.79	17.09	20.05
EBITA, 2 Yr. CAGR %	17.87	19.4	6.04	19.43	22.48
EBIT, 2 Yr. CAGR %	17.98	19.54	6.08	19.54	22.68
Earnings From Cont. Operations, 2 Yr. CAGR %	18.39	19.65	7.15	19.75	20.3
Net Income, 2 Yr. CAGR %	18.39	19.65	7.15	19.75	20.3
Normalized Net Income, 2 Yr. CAGR %	17.98	19.54	6.08	19.54	22.68
Diluted EPS Before Extra, 2 Yr. CAGR %	19.8	21.59	9.65	20.51	20.66
Accounts Receivable, 2 Yr. CAGR %	12.06	11.89	8.44	13.36	2.14
Net Property, Plant and Equip., 2 Yr. CAGR %	-23.36	-6.6	-5.49	-4.44	10.88
Total Assets, 2 Yr. CAGR %	-0.12	-3.7	4.64	17.73	18.92
Tangible Book Value, 2 Yr. CAGR %	8.46	-7.85	9.52	36.21	33.4
Common Equity, 2 Yr. CAGR %	5.81	-4.22	7.98	26.2	26.17
Cash From Operations, 2 Yr. CAGR %	-8.8	-6.63	21.5	24.39	25.23
Capital Expenditures, 2 Yr. CAGR %	-4.01	23.55	-0.98	16.55	24.55
Levered Free Cash Flow, 2 Yr. CAGR %	-19.41	-15.95	57.27	20.52	30.13
Unlevered Free Cash Flow, 2 Yr. CAGR %	-19.41	-15.95	57.27	20.52	30.13
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	2.75	6.66	12.9	11.49	10.08
Gross Profit, 3 Yr. CAGR %	6.82	7.92	11.57	11.3	13.74
EBITDA, 3 Yr. CAGR %	8.67	9.63	13.68	11.51	16.83
EBITA, 3 Yr. CAGR %	11.1	11.6	17.02	12.58	19.03
EBIT, 3 Yr. CAGR %	11.17	11.67	17.13	12.65	19.18
Earnings From Cont. Operations, 3 Yr. CAGR %	12.45	11.89	18.05	12.74	18.47
Net Income, 3 Yr. CAGR %	12.45	11.89	18.05	12.74	18.47
Normalized Net Income, 3 Yr. CAGR %	11.17	11.67	17.13	12.65	19.18
Diluted EPS Before Extra, 3 Yr. CAGR %	14.16	13.92	19.94	14.47	19.31
Accounts Receivable, 3 Yr. CAGR %	5	7.21	14.48	8.03	7.73
Net Property, Plant and Equip., 3 Yr. CAGR %	33.27	-17.89	-6.15	-4.88	5.23
Total Assets, 3 Yr. CAGR %	9.3	-1.82	2.29	9.55	17.74
Tangible Book Value, 3 Yr. CAGR %	4.18	2.11	4.02	18.86	33.11
Common Equity, 3 Yr. CAGR %	2.92	2.14	3.96	14.88	24.93
Cash From Operations, 3 Yr. CAGR %	-5.09	0.6	1.69	23.72	23.67
Capital Expenditures, 3 Yr. CAGR %	24.98	-6.65	19.25	6.24	19.89
Levered Free Cash Flow, 3 Yr. CAGR %	-25.3	15.21	-9.47	50.67	21.17
Unlevered Free Cash Flow, 3 Yr. CAGR %	-25.3	15.21	-9.47	50.67	21.17
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	4.5	5.17	5.95	8.62	11.64
Gross Profit, 5 Yr. CAGR %	7.74	8.09	6.59	10.74	13.5
EBITDA, 5 Yr. CAGR %	9.62	9.5	7.51	12.56	16.18
EBITA, 5 Yr. CAGR %	12.31	12.15	9.05	14.67	19.18
EBIT, 5 Yr. CAGR %	12.19	12.04	9.1	14.76	19.32
Earnings From Cont. Operations, 5 Yr. CAGR %	17.64	13.21	10.3	14.97	18.94
Net Income, 5 Yr. CAGR %	17.64	13.21	10.3	14.97	18.94
Normalized Net Income, 5 Yr. CAGR %	12.19	12.04	9.1	14.76	19.32
Diluted EPS Before Extra, 5 Yr. CAGR %	19.37	15.06	12.33	16.58	20.28
Accounts Receivable, 5 Yr. CAGR %	5.62	4.53	6.36	9.63	9.38
Net Property, Plant and Equip., 5 Yr. CAGR %	16.9	13	16.15	-12.75	0.33
Total Assets, 5 Yr. CAGR %	12.02	7.53	7.41	5.58	8.65
Tangible Book Value, 5 Yr. CAGR %	14.8	4.78	6.28	14.59	14.9
Common Equity, 5 Yr. CAGR %	8.9	3.38	4.92	11.16	12.33
Cash From Operations, 5 Yr. CAGR %	5.25	5.77	4.76	9.51	10.52
Capital Expenditures, 5 Yr. CAGR %	-0.8	-1.01	13.87	2.02	21.34
Levered Free Cash Flow, 5 Yr. CAGR %	0.37	13.41	0.61	17.31	4.67
Unlevered Free Cash Flow, 5 Yr. CAGR %	0.37	13.41	0.61	17.31	4.67